Liying Chen
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Triptonide suppresses the FOXK1/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma.
Journal: Genes & genomics
Published: May 28, 2025
E2F7 promotes ESCC progression and cisplatin resistance through transcriptional activation of DVL3 and the Wnt signaling pathway.
Journal: World journal of surgical oncology
Published: April 22, 2025
AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis.
Journal: Heliyon
Published: November 06, 2023
FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma.
Journal: Scientific reports
Published: December 12, 2022
Pure proton therapy for skull base chordomas and chondrosarcomas: A systematic review of clinical experience.
Journal: Frontiers in oncology
Published: August 11, 2022
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1.
Journal: Clinical & experimental metastasis
Published: February 17, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026